Objectives and Design of BLEEDS: A Cohort Study to Identify New Risk Factors and Predictors for Major Bleeding during Treatment with Vitamin K Antagonists-Reference-Cited by-同舟云学术

Objectives and Design of BLEEDS: A Cohort Study to Identify New Risk Factors and Predictors for Major Bleeding during Treatment with Vitamin K Antagonists

Published:2016-12-09 Issue:12 Volume:11 Page:e0164485
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

van Rein Nienke,Lijfering Willem M.,Bos Mettine H. A.,Herruer Martien H.,Vermaas Helga W.,van der Meer Felix J. M.,Reitsma Pieter H.

Funder

Hartstichting

Center for Translational Molecular Medicine

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference28 articles.

1. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition);J Ansell;Chest,2008

2. Bleeding complications in oral anticoagulant therapy. An analysis of risk factors;FJ van der Meer;Arch Intern Med,1993

3. Bleeding risks associated with vitamin K antagonists;LA Linkins;Blood Rev,2013

4. Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition);S Schulman;Chest,2008

5. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin;RJ Beyth;Am J Med,1998

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma thrombin generation in the presence of TIX-5 may contribute significantly to a prediction model for major bleeding in patients on VKA anticoagulant therapy;Thrombosis Update;2024-06

2. Genetic polymorphisms and major bleeding risk during vitamin K antagonists treatment: The BLEEDS case‐cohort;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2024-04-30

3. The effect of COVID-19 vaccination on anticoagulation stability in adolescents and young adults using vitamin K antagonists;Thrombosis Research;2023-08

4. Effect of PCC on Thrombin Generation among Patients on Factor Xa Inhibitors with Major Bleeding or Needing Urgent Surgery (GAUGE): Design and Rationale;TH Open;2023-07

5. Selective Serotonin Reuptake Inhibitor Use and Risk of Major Bleeding during Treatment with Vitamin K Antagonists: Results of A Cohort Study;Thrombosis and Haemostasis;2022-10-08